Actinobac Biomed, Inc.

Actinobac Biomed, Inc.

Actinobac Biomed, Inc.

Actinobac Biomed focuses on the development of pharmaceutical technologiesderived from agents that target LFA-1.
Type
B2b
Founded
2009
Raised
$5M
Follow us
Alexa global traffic share
21 Feb 2013
$100,000
Venture capital (Series B)
20 Mar 2009
$500,000
Venture capital